The late adverse events of rituximab therapy – rare but there!

Rituximab-associated acute thrombocytopenia: An under-diagnosed phenomenon

(2009) Ron Ram et al.   AMERICAN JOURNAL OF HEMATOLOGY

Immunoglobulin M ‘Flare’ after rituximab-associated acute tubular necrosis in Waldenström’s macroglobulinemia

(2009) Hassane Izzedine et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Rituximab Maintenance for the Treatment of Patients With Follicular Lymphoma: Systematic Review and Meta-analysis of Randomized Trials

(2009) Liat Vidal et al.   JNCI-Journal of the National Cancer Institute

Late reactivation of resolved hepatitis B virus infection: An increasing complication post rituximab-based regimens treatment?

(2008) Maria J. Garcia-Rodriguez et al.   AMERICAN JOURNAL OF HEMATOLOGY

The effectiveness of lamivudine in preventing hepatitis B viral reactivation in rituximab-containing regimen for lymphoma

(2008) Yi-Fu He et al.   ANNALS OF HEMATOLOGY

Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials

(2008) C Salliot et al.   ANNALS OF THE RHEUMATIC DISEASES

Clinical and prognostic analysis of hepatitis B virus infection in diffuse large B-cell lymphoma

(2008) Feng Wang et al.   BMC CANCER

A randomized trial of etoposide and G-CSF with or without rituximab for PBSC mobilization in B-cell non-Hodgkin's lymphoma

(2008) E Copelan et al.   BONE MARROW TRANSPLANTATION

Concomitant treatment with lamivudine renders cladribine inactive by inhibition of its phosphorylation

(2008) Haithem Chtioui et al.   BRITISH JOURNAL OF HAEMATOLOGY

Three cases of Pneumocystis jirovecii pneumonia (PCP) during first-line treatment with rituximab in combination with CHOP-14 for aggressive B-cell non-Hodgkin’s lymphoma

(2008)   EUROPEAN JOURNAL OF HAEMATOLOGY

Liver dysfunction after chemotherapy in lymphoma patients infected with hepatitis C

(2008) Omer Dizdar et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Risk factors for infection in haematology patients treated with rituximab

(2008) Yuko Kanbayashi et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Hepatitis B virus-related liver disease in isolated anti-hepatitis B-core positive lymphoma patients receiving chemo- or chemo-immune therapy

(2008) C. Targhetta et al.   HAEMATOLOGICA

Enhancement of anti-lymphoma immuno-effects mediated by dendritic cells pulsed with heat-stressed and rituximab-coated CD20+ lymphoma cells

(2008) Limei Ai et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Increased incidence of interstitial pneumonia by CHOP combined with rituximab

(2008) Daisuke Ennishi et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Rituximab-Induced Hepatitis C Virus Reactivation After Spontaneous Remission in Diffuse Large B-Cell Lymphoma

(2008) Ching-Yun Hsieh et al.   JOURNAL OF CLINICAL ONCOLOGY

Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without Rituximab

(2008) Winnie Yeo et al.   JOURNAL OF CLINICAL ONCOLOGY

Molecular characterization of a variant virus that caused de novo hepatitis B without elevation of hepatitis B surface antigen after chemotherapy with rituximab

(2008) Masami Miyagawa et al.   JOURNAL OF MEDICAL VIROLOGY

Pneumocystis jiroveci Pneumonia in Patients with Non-Hodgkin's Lymphoma Receiving Chemotherapy Containing Rituximab

(2008) Hung Chang et al.   Journal of the Chinese Medical Association

Progressive multifocal leukoencephalopathy after rituximab in a patient with relapsed follicular lymphoma and low IgG levels and a low CD4+lymphocyte count

(2008) Georg Hopfinger et al.   LEUKEMIA & LYMPHOMA

Fludarabine, Cyclophosphamide and Rituximab (FCR) induced pulmonary hypertension in Waldenström macroglobulinemia

(2008) Vladimir LJ Lazarevic et al.   LEUKEMIA & LYMPHOMA

Interstitial pneumonitis during rituximab-containing chemotherapy for non-Hodgkin lymphoma

(2008) Xin Liu et al.   LEUKEMIA & LYMPHOMA

Rituximab combined with chemotherapy for lymphoma during pregnancy

(2008) J. Rey et al.   LEUKEMIA RESEARCH

Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis

(2008) Daniel Tesfa et al.   MEDICAL ONCOLOGY

Post‐marketing safety of antineoplasic monoclonal antibodies: rituximab and trastuzumab

(2008) V. González et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Persistent and Relapsing Babesiosis in Immunocompromised Patients

(2007) P. J. Krause et al.   CLINICAL INFECTIOUS DISEASES

Catastrophic gastrointestinal manifestations of post-transplant lymphoproliferative disorder

(2007) Y.-C. Hsu et al.   DIGESTIVE AND LIVER DISEASE

Safety, efficacy, and immune reconstitution after rituximab therapy in pediatric patients with chronic or refractory hematologic autoimmune cytopenias

(2007) Aarati Rao et al.   PEDIATRIC BLOOD & CANCER